QP Wealth Management’s Abivax ABVX Stock Holding History

QP Wealth Management’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,528	Closed	-$745K	–	67
2025 Q4	$745K	Buy	+5,528	New	+$603K	0.66%	37

Other funds holding ABVX

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

QP Wealth Management's ABVX Position: Q1 2026 in Review

QP Wealth Management sold out of Abivax (ABVX) in Q1 2026, closing a stake of 5,528 shares — an estimated $745K sold.

QP Wealth Management first reported a position in ABVX in Q4 2025 and held it in 1 quarter. The position peaked at $745K in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

QP Wealth Management reported no remaining Abivax position as of Q1 2026 after selling out during the quarter.
QP Wealth Management sold 5,528 Abivax shares in Q1 2026, an estimated $745K.
QP Wealth Management first reported a position in Abivax in Q4 2025 and held it in 1 quarter.
QP Wealth Management's Abivax position peaked at $745K in Q4 2025.
254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on QP Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.